IOMX THERAPEUTICS
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By systematically screening human tumor cells, the Company has already identified a number of novel targets and analyzed their mode of action. The Company was founded on the successful concept of cancer immune-checkpoint therapy, which works by breaking down the inherent resistance mechanisms of tumors against immune attack. Immune resistance of tumors is often mediated by cell surface molecules that stimulate immune-inhibitory receptors on T cells. Reactivating the host immune response by neutralizing these negative interactions is the idea behind cancer immune-checkpoint therapy.
IOMX THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Munich, Bayern, Germany
Country:
Germany
Website Url:
http://www.iomx.com
Total Employee:
11+
Status:
Active
Contact:
+49 (0)89 8999 7090 0
Email Addresses:
[email protected]
Total Funding:
105 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving Apache Mobile Non Scaleable Content PHP PHP 7 JQuery CDN GoDaddy SSL W3 Total Cache
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
MAGiQ Therapeutics
MAGiQ Therapeutics focuses on the development and licensing of regenerative medicine products generated from iPS cells.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Series B - IOmx Therapeutics
MIG
MIG investment in Series B - IOmx Therapeutics
ATHOS Service
ATHOS Service investment in Series B - IOmx Therapeutics
M Ventures
M Ventures investment in Series B - IOmx Therapeutics
Wellington Partners
Wellington Partners investment in Series B - IOmx Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - IOmx Therapeutics
MPM Capital
MPM Capital investment in Series A - IOmx Therapeutics
Wellington Partners
Wellington Partners investment in Series A - IOmx Therapeutics
M Ventures
M Ventures investment in Series A - IOmx Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-03 | iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development |
Official Site Inspections
http://www.iomx.com Semrush global rank: 4.81 M Semrush visits lastest month: 1.89 K
- Host name: 70.21.180.107.host.secureserver.net
- IP address: 107.180.21.70
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
